Target Price | $96.18 |
Price | $70.43 |
Potential | 36.56% |
Number of Estimates | 22 |
22 Analysts have issued a price target DexCom, Inc. 2025 . The average DexCom, Inc. target price is $96.18. This is 36.56% higher than the current stock price. The highest price target is $130.00 84.58% , the lowest is $75.00 6.49% . | |
A rating was issued by 27 analysts: 20 Analysts recommend DexCom, Inc. to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the DexCom, Inc. stock has an average upside potential 2025 of 36.56% . Most analysts recommend the DexCom, Inc. stock at Purchase. |
22 Analysts have issued a sales forecast DexCom, Inc. 2024 . The average DexCom, Inc. sales estimate is $4.0b . This is 1.99% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $4.1b 3.11% , the lowest is $4.0b 1.20% .
This results in the following potential growth metrics:
2023 | $3.6b | 24.49% |
---|---|---|
2024 | $4.0b | 10.79% |
2025 | $4.6b | 15.60% |
2026 | $5.4b | 17.46% |
2027 | $6.3b | 16.12% |
2028 | $7.3b | 15.05% |
13 Analysts have issued an DexCom, Inc. EBITDA forecast 2024. The average DexCom, Inc. EBITDA estimate is $1.2b . This is 31.91% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.2b 38.51% , the lowest is $1.1b 29.30% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $784m | 43.25% |
---|---|---|
2024 | $1.2b | 49.27% |
2025 | $1.4b | 21.04% |
2026 | $1.7b | 20.47% |
2027 | $2.1b | 21.99% |
2028 | $2.5b | 19.55% |
2023 | 21.64% | 15.07% |
---|---|---|
2024 | 29.15% | 34.73% |
2025 | 30.52% | 4.70% |
2026 | 31.30% | 2.56% |
2027 | 32.88% | 5.05% |
2028 | 34.17% | 3.92% |
12 DexCom, Inc. Analysts have issued a net profit forecast 2024. The average DexCom, Inc. net profit estimate is $655m . This is 0.86% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $701m 8.01% , the lowest is $613m 5.56% .
This results in the following potential growth metrics and future Net Margins:
2023 | $521m | 62.50% |
---|---|---|
2024 | $655m | 25.69% |
2025 | $796m | 21.64% |
2026 | $971m | 21.88% |
2027 | $1.2b | 26.46% |
2028 | $1.4b | 15.88% |
2023 | 14.38% | 30.54% |
---|---|---|
2024 | 16.31% | 13.42% |
2025 | 17.17% | 5.27% |
2026 | 17.81% | 3.73% |
2027 | 19.40% | 8.93% |
2028 | 19.54% | 0.72% |
12 Analysts have issued a DexCom, Inc. forecast for earnings per share. The average DexCom, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $1.63 . This is 0.62% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $1.75 8.02% , the lowest is $1.53 5.56% .
This results in the following potential growth metrics and future valuations:
2023 | $1.30 | 62.50% |
---|---|---|
2024 | $1.63 | 25.38% |
2025 | $1.99 | 22.09% |
2026 | $2.42 | 21.61% |
2027 | $3.06 | 26.45% |
2028 | $3.55 | 16.01% |
Current | 43.40 | 56.73% |
---|---|---|
2024 | 43.10 | 0.69% |
2025 | 35.44 | 17.77% |
2026 | 29.07 | 17.97% |
2027 | 22.99 | 20.92% |
2028 | 19.84 | 13.70% |
Based on analysts' sales estimates for 2024, the DexCom, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 6.90 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 7.03 .
This results in the following potential growth metrics and future valuations:
Current | 7.04 | 39.31% |
---|---|---|
2024 | 6.90 | 1.97% |
2025 | 5.97 | 13.50% |
2026 | 5.08 | 14.87% |
2027 | 4.38 | 13.89% |
2028 | 3.80 | 13.08% |
Current | 7.17 | 38.63% |
---|---|---|
2024 | 7.03 | 1.95% |
2025 | 6.08 | 13.50% |
2026 | 5.18 | 14.86% |
2027 | 4.46 | 13.89% |
2028 | 3.88 | 13.08% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.